Ethics in American health 2: An ethical framework for health system reform

American Journal of Public Health

Volumn 98, Issue 10, 2008, Pages 1756-1763

  Ruger, Jennifer Prah ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSENSUS; ECONOMIC ASPECT; ENVIRONMENTAL ASPECTS AND RELATED PHENOMENA; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH INSURANCE; MEDICAL ETHICS; REVIEW; COOPERATION; COST BENEFIT ANALYSIS; DISABLED PERSON; ETHICAL THEORY; ETHICS; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; INSURANCE; MANAGEMENT; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PATIENT ADVOCACY; SOCIAL JUSTICE; SOCIAL PSYCHOLOGY; UNITED STATES;

CONSENSUS; COOPERATIVE BEHAVIOR; COST-BENEFIT ANALYSIS; DECISION MAKING, ORGANIZATIONAL; DISABLED PERSONS; EFFICIENCY, ORGANIZATIONAL; ETHICAL THEORY; EVIDENCE-BASED MEDICINE; HEALTH CARE REFORM; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; PATIENT ADVOCACY; POLICY MAKING; SOCIAL JUSTICE; SOCIAL VALUES; UNITED STATES; UNIVERSAL COVERAGE;

EID: 52449125144     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2007.121350     Document Type: Review

References (81)

1. Ruger JP. Health and social justice. Lancet. 2004;364:1075-1080.
2. Ruger JP. Ethics of the social determinants of health. Lancet. 2004;364:1092-1097.
3. Ruger JP. Toward a theory of a right to health: capability and incompletely theorized agreements. Yale J Law Humanit. 2006;18:273-326.
4. Ruger JP. Health, capability, and justice: toward a new paradigm of health ethics, policy and law. Cornell J Law Public Policy. 2006;15:403-482.
5. Ruger JP. Aristotelian Justice and Health Policy: Capability and Incompletely Theorized Agreements [dissertation]. Cambridge, MA: Harvard University; 1998.
6. Aristotle. The Nicomachean Ethics. 2nd ed. Indianapolis, IN: Hackett Publishing Co; 1999.
7. Nussbaum MC. Nature, function, and capability: Aristotle on political distribution. In: von Gunther Patzig H. Aristoteles Politik. Gottingen, Germany: Vandenhoeck & Ruprecht; 1990.
8. Nussbaum MC. The good as discipline, the good as freedom. In: Crocker D, ed. The Ethics of Consumption: The Good Life, Justice and Global Stewardship. Lanham, MD: Rowman & Littlefield; 1998:312-341.
9. Nussbaum MC. Human functioning and social justice: in defense of Aristotelian essentialism. Polit Theory. 1992;20:202-246.
10. Aristotle. The Politics. Chicago, IL: University of Chicago Press; 1994.
11. Sen AK. Inequality Reexamined. Cambridge, MA: Harvard University Press; 1992.
12. Sen AK. Commodities and Capabilities. Amsterdam, Netherlands: North-Holland; 1985.
13. Sen AK. Development as Freedom. Oxford, England: Oxford University Press; 1999.
14. Ruger JP. Rethinking equal access: agency, quality and norms. J Global Public Health. 2007;2:78-96.
15. Daniels N. Just Health Care. Cambridge, England: Cambridge University Press; 1985.
16. Brown L, ed. The New Shorter Oxford English Dictionary on Historical Principles. Vol. 2, 4th ed. Oxford, England: Oxford University Press; 1993.
17. Rawls J. A Theory of Justice. Cambridge, MA: Harvard University Press; 1971.
18. Hall MA. Making Medical Spending Decisions: The Law, Ethics, and Economics of Rationing Mechanisms. Oxford, England: Oxford University Press; 1997.
19. Ruger JP. Ethics and governance of global health inequalities. J Epidemiol Community Health. 2006;60:998-1003.
20. Daniels N, Sabin JE. Setting Limits Fairly: Can We Learn to Share Medical Resources? Oxford, England: Oxford University Press; 2002.
21. Ruger JP. Moral foundations of health insurance. Q J Med. 2007;100:53-57.
22. Ruger JP. Democracy and health. Q J Med. 2005;98:299-304.
23. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 4th ed. Oxford, England: Oxford University Press; 1994.
24. Gutmann A. For and against equal access to health care. Milbank Q. 1981;59:542-560.
25. Buchanan AE. The right to decent minimization of health care. Philos Public Aff. 1984;13:55-78.
26. Meel B. The myth of child rape as a cure for HIV/AIDS in Transkei: a case report. Med Sci Law. 2003;43:85-88.
27. Perkins H, Haines M, Rice R. Misperceiving the college drinking norm and related problems: a nationwide study of exposure to prevention information, perceived norms and student alcohol misuse. J Stud Alcohol. 2005;66:470-478.
28. Wolfson S. Students' estimates of the prevalence of drug use: evidence for a false consensus effect. Psychol Addict Behav. 2000;14:295-298.
29. Van Doorslaer E, Wagstaff A, Rutten F, eds. Equity in the Finance and Delivery of Healthcare: An International Perspective. Oxford, England: Oxford University Press; 1993.
30. Duchon L, Shoen C, Doty MM, Davis K, Strumf E, Bruegman S. Security Matters: How Instability in Health Insurance Puts US Workers at Risk. New York, NY: Commonwealth Fund; 2001. Report 512.
31. World Health Report: Making a Difference. Geneva, Switzerland: World Health Organization; 1999.
32. Woolhander S, Himmelstein DU. Cost of care and administration at for-profit and other hospitals in the United States. N Engl J Med. 1997;336:769-774.
33. Mills AJ, Ranson MK. The design of health systems. In: Merson MH, Black RE, Mills A, eds. International Public Health: Diseases, Programs, Systems, and Policies. Gaithersburg, MD: Aspen Publishers; 2001:515-558.
34. Brook RH, Lohr KN. Will we need to ration effective health care? Issues Sci Technol. 1986;3:68-77.
35. Brook RH. The RAND/UCLA appropriateness method. In: McCormick KA, Moore SR, Siegel RA, eds. Clinical Practice Guideline Development: Methodology Perspectives. Rockville, MD: Agency for Health Care Policy and Research; 1994:59-70. AHCPR publication 95-0009.
36. Kahan JP, Bernstein SJ, Leape LL, et al. Measuring the necessity of medical procedures. Med Care. 1994;32:357-365.
37. RAND/UCLA appropriateness method user's manual. Available at: http://www.rand.org/pubs/monograph_reports/MR1269/index.html. Accessed April 13, 2008.
38. Black C, Peterson S, Mansfield J, Thlivens M. Using population-based data to enhance clinical practice guideline development. Med Care. 1999;37(suppl 6):JS254-JS263.
39. Broder MS, Kanouse DE, Mittman BS, Bernstein SJ. The appropriateness of recommendations for hysterectomy. Obstet Gynecol. 2000;95:199-205.
40. Bates DW, Miller E, Bernstein SJ, Hauptman PJ, Leape LL. Coronary angiography and angioplasty after acute myocardial infarction. Ann Intern Med. 1997;126:539-550.
41. Shojania KG, Yokoe D, Platt R, Fiskio J, Ma'luf N, Bates DW. Reducing vancomycin use utilizing a computer guideline: results of a randomized controlled trial. J Am Med Inform Assoc. 1998;5:554-562.
42. Miller TE. Center stage on the patient protection agenda: grievance and appeal rights. J Law Med Ethics. 1998;26:89-99.
43. Orentlicher D. Rationing and the Americans with Disabilities Act. JAMA. 1994;271:308-314.
44. Hadorn DC. The problem of discrimination in health care priority setting. JAMA. 1992;268:423-441.
45. Anand S, Hanson K. Disability-adjusted life years: a critical review. J Health Econ. 1997;6:685-702.
46. Brock DW. Priority to the worse off in health care resource prioritization. In: Rhodes R, Battin MP, Silvers A, eds. Medicine and Social Justice. Oxford, England: Oxford University Press; 2002:362-372.
47. Menzel PT. Oregon's denial: disabilities and quality of life. Hastings Cent Rep. 1992;22(6):21-25.
48. Crossley MA. Of diagnoses and discrimination: discriminatory nontreatment of infants with HIV infection. Columbia Law Rev. 1993;93:1581-1667.
49. Orentlicher D. Utility, equality, and health care needs in persons with disabilities. In: Francis LP, Silvers A, eds. Americans with Disabilities: Exploring Implications of the Law for Individuals and Institutions. New York, NY: Routledge; 2000:236-243.
50. Daniels N. Justice, health, and healthcare. Am J Bioeth. 2001;2:2-16.
51. Elhauge E. Allocating health care morally. Calif Law Rev. 1994;82:1449-1544.
52. USC §§12101-12213 (1994).
53. USC §§701-797(b) (1994).
54. Equal Employment Opportunity Commission. Enforcement guidance on reasonable accommodation and undue hardship under the Americans with Disabilities Act, 2000. Available at: http://www.eeoc.gov/facts/accommodation. html. Accessed April 13, 2008.
55. Maple Syrup Urine Disease Support Group Web site. Available at: http://www.msud-support.org/index.html. Accessed April 13, 2008. 56. American Thoracic Society. Withholding and withdrawing life-sustaining therapy. Ann Intern Med. 1991;115:478-485.
56. School Board v Arline, 480 US 273 (1987).
57. Strathie v Department of Transportation, 716 F2d 227 (3rd Cir 1983).
58. Enthoven A, Kronick R. A consumer-choice health plan for the 1990s: universal health insurance in a system designed to promote quality and economy. N Engl J Med. 1989;320:29-37.
59. Maynard A, Bloor K. Universal coverage and cost control: the United Kingdom National Health Service. J Health Hum Serv Adm. 1998;20:441.
60. Kaiser Family Foundation. State health facts online. Available at: http://statehealthfacts.kff.org. Accessed April 13, 2008.
61. Newhouse JP. Free for All: Lessons From the RAND Health Insurance Experiment. Cambridge, MA: Harvard University Press; 1993.
62. Aaron HJ, Schwartz WB. The Painful Prescription: Rationing Hospital Care. Washington, DC: Brookings Institution; 1984.
63. Mechanic D. Socioeconomic status and health. In: Bunker JP, Kehrer BH, Gomby DS, eds. Pathways to Health: The Role of Social Factors. Menlo Park, CA: Kaiser Family Foundation; 1989:9-26.
64. Topol EJ, Holmes DR, Rogers WJ. Coronary angiography after thrombolytic therapy for acute myocardial infarction. Ann Intern Med. 1991;114:877-885.
65. Kuntz KM, Tsevat J, Weinstein MC, Goldman L. Expert panel vs decision-analysis recommendations for postdischarge coronary angiography after myocardial infarction. JAMA. 1999;282:2246-2251.
66. Newhouse JP. Why is there a quality chasm? Health Aff. 2002;21:13-25.
67. Rosenthal MB, Landon BE, Normand SL, Frank RG, Epstein AM. Pay for performance in commercial HMOs. N Engl J Med. 2006;355:1895-1902.
68. Robinson R. Cost-minimization analysis. BMJ. 1993;307:686-689.
69. Smith TJ, Hillner BE, Schmitz N, et al. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood-progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma. J Clin Oncol. 1997;15:5-10.
70. Gardner MO. Cost analysis in obstetrics and gynecology. Clin Obstet Gynecol. 1998;41:296-306.
71. Dorsey JH, Holtz PM, Griffiths RI, McGrath MM, Steinberg EP. Costs and charges associated with three alternative techniques of hysterectomy. N Engl J Med. 1996;335:476-482.
72. Sweetenham J, Hieke K, Kerrigan M, et al. Cost minimization analysis of CHOP, fludarabine, and rituximab for the treatment of relapsed indolent b-cell non-Hodgkin's lymphoma in the U.K. Br J Haematol. 1999;106:47-54.
73. Anderson C, Mhurchu CN, Rubenach S, Clark M, Spencer C, Winsor A. Home or hospital for stroke rehabilitation? Results of a randomized controlled trial II: cost minimization analysis at 6 months. Stroke. 2000;31:1032-1037.
74. Sun R, Watcha MF, White PF, et al. A cost comparison of methohexital and propofol for ambulatory anesthesia. Anesth Analg. 1999;89:311-316.
75. Menzel PT. Strong Medicine: The Ethical Rationing of Health Care. Oxford, England: Oxford University Press; 1990.
76. Nord E, Pinto JL, Richardson J, Menzel P, Ubel P. Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Econ. 1999;8:25-39.
77. Williams A. QALYs and ethics: a health economist's perspective. Soc Sci Med. 1996;43:1795-1804.
78. Silverman EM, Skinner JS, Fisher ES. The association between for-profit hospital ownership and increased Medicare spending. N Engl J Med. 1999;341:420-426.
79. Barnato AE, Herndon MB, Anthony DL, et al. Are regional variations in end-of-life care intensity explained by patient preferences? A study of the US Medicare population. Med Care. 2007;45:386-393.
80. Chassin MR. Achieving and sustaining improved quality: lessons from New York State and cardiac surgery. Health Aff. 2002;21:40-51.
81. Cutler DM, McClellan M. Is technological change in medicine worth it? Health Aff. 2001;20:11-29.